Advanced Lipid Panel, Cardio IQ®

Includes

• Cardio IQ® Cholesterol, Total
• Cardio IQ® HDL Cholesterol
• Cardio IQ® Triglycerides
• Cardio IQ® Non-HDL and Calculated Components
• Cardio IQ® Lipoprotein Fractionation, Ion Mobility
• Cardio IQ® Apolipoprotein B
• Cardio IQ® Lipoprotein (a)
•  
• If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge (CPT code(s): 83721).

Patient Preparation

Fasting is not required prior to collection of a lipid panel.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.

Methodology

Enzymatic • Nephelometry • Immunoturbidometric • Ion Mobility • Spectrophotometry (SP)

Assay Category

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

See Laboratory Report

Alternative Name(s)

CardioIQ®,Cardio IQ® Advanced Lipid Panel

LOINC® Codes, Performing Laboratory